by admin on | 2024-10-06 09:52:58
Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 142
The Minister of Health, Dr Sabin
Nsanzimana, announced that Gilead Sciences, which manufactures drugs for
various infectious diseases, has approved 5,000 doses of Remdesivir for the
treatment of Murburg.
The Murburg epidemic has been present for
more than a week in Rwanda, the latest figures show that five people have been
treated and recovered, while the number of casualties is 11 and the number of
people receiving medical attention so far is 21.
Minister Dr Sabin Nsanzimana during a press
conference organized by Africa CDC, on October 3, 2024, announced that Gilead
Sciences has agreed to donate 5000 doses of the drug used to treat Marburg
patients to Rwanda.
"We hope to get five thousand doses of
Remdesivir to the patients who need it the most," he said.
He also said that there are various
companies in talks with Rwanda to speed up the vaccine so that in a few days it
will also be distributed in Rwanda.
Africa CDC has confirmed that it is going
to send experts and its director who will arrive in Rwanda next week, with the
aim of helping the country deal with this epidemic.
Health authorities in Rwanda confirm that
they are doing everything possible to ensure that no infected person leaves the
country and carries the infection to another place.
Health authorities say that a person can be
infected with Marburg for between three and 21 days without showing symptoms.
Its initial symptoms are similar to those
of other diseases, especially Malaria. These include sudden high fever, severe
headache, joint pain, muscle aches and even nerve pain.
It's just that as the days go by the
symptoms change as the body deteriorates.
Medical experts believe that patients who
are treated early can recover, but there is a risk of death between 26% and
89%.
The way to prevent it is to strengthen
hygiene measures and avoid sharing equipment with someone who has symptoms
similar to those of this disease.
Minister Dr. Sabin Nsanzimana revealed that
Gilead Sciences Inc. has approved a drug to treat Marburg in Rwanda.
Marc N
………………………………………………………………………….
Previous news
Accountancy jobs
https://andika.rw/news-details.php?nid=171
Here's what researchers say about the noise made by those involved
during sexual intercourse
https://andika.rw/news-details.php?nid=170
End